Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Open Access
- 1 January 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (1), 252-257
- https://doi.org/10.1182/blood.v99.1.252
Abstract
Signal transducer and activator of transcription (STAT) proteins are involved in hematopoietic cytokine receptor signaling pathways that regulate cell proliferation, differentiation, and survival. STATs are dysregulated in acute myeloid leukemia (AML); mechanisms of dysregulation include constitutive activation and truncation of the C-terminal transactivation domain; the latter results in a β isoform that has a trans-dominant negative effect on gene induction mediated by the full-length STATα form. It was hypothesized that constitutive STAT activity might correlate with unfavorable treatment outcome in AML. Pretreatment bone marrow samples from 63 adult patients with AML were analyzed by electrophoretic mobility shift assay for the presence of STAT DNA-binding activity. Isoforms and relative levels of STAT proteins were determined by immunoblotting. Constitutive STAT3 activity was detected in samples from 28 (44%) patients. Pretreatment clinical characteristics, expression of STATα/β isoforms, and treatment regimens did not differ significantly between patients with and without constitutive STAT3 activity. Disease-free survival (DFS) was significantly shorter in patients with than in patients without constitutive STAT3 activity (median 8.7 vs 20.6 months;P = .01). Overall survival did not differ significantly. The subgroup of patients with constitutive STAT3 activity and the STAT3β isoform had the shortest DFS (P = .006) and shorter overall survival (P = .049) than all other patients. Whether adverse treatment outcome is attributable to constitutive STAT activity itself or to a process that leads to constitutive STAT activity remains to be determined. This is the first demonstration of a prognostic significance for STAT proteins in a malignancy.Keywords
This publication has 40 references indexed in Scilit:
- STAT signaling in the pathogenesis and treatment of leukemiasOncogene, 2000
- The Jak-STAT pathwayMolecular Immunology, 2000
- IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathwayEuropean Journal of Immunology, 1999
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- STATs: Signal Transducers and Activators of TranscriptionCell, 1996
- c-mplExpression in Hematologic DisordersLeukemia & Lymphoma, 1995
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952
- On a Test of Whether one of Two Random Variables is Stochastically Larger than the OtherThe Annals of Mathematical Statistics, 1947